Literature DB >> 2293602

Vitamin E uptake by human intestinal cells during lipolysis in vitro.

M G Traber1, I Goldberg, E Davidson, N Lagmay, H J Kayden.   

Abstract

Vitamin E uptake by Caco-2 cells, a human intestinal cell line, was studied by incubating the cells with alpha-tocopherol/triglyceride emulsions with or without bile activated lipase or lipoprotein lipase. During a 1-h incubation, vitamin E was transferred to Caco-2 cells only in the presence of triglyceride hydrolysis by bile activated lipase and not by lipoprotein lipase. Incubation with either lipase resulted in hydrolysis of approximately 20% of the medium [3H]-triolein to free fatty acids and a 3-5-fold increase in cellular radioactivity. In the absence of lipases but the presence of taurocholate, addition of oleic acid in an amount equal to the molar concentration of triglyceride (5.7 mM) to triglyceride emulsions containing either alpha-tocopherol or cholesteryl ester resulted in an increase in cellular [3H]-triglyceride and alpha-tocopherol or cholesteryl ester. We suggest that the absorption of hydrophobic molecules such as vitamin E may occur in the presence of bile and amphipathic lipids via the uptake of micellar neutral lipids by the intestine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293602     DOI: 10.1016/0016-5085(90)91296-i

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents.

Authors:  G Ranaldi; K Islam; Y Sambuy
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

2.  Synthesis and secretion of the pancreatic-type carboxyl ester lipase by human endothelial cells.

Authors:  F Li; D Y Hui
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

3.  Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.

Authors:  Thomas M Kitzler; Aala Jaberi; Gerald Sendlhofer; Peter Rehak; Christian Binder; Eva Petnehazy; Rudolf Stacher; Peter Kotanko
Journal:  Wien Klin Wochenschr       Date:  2012-04-24       Impact factor: 1.704

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.